← FDA DRUG APPROVALS

FDA ANDA · ANDA087902

TRIAMCINOLONE ACETONIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA087902
TYPE
ANDA
ORIGINAL APPROVAL
1982-12-27
LATEST ACTION
1993-04-08
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 0.1% · OINTMENT · TOPICAL

Approval history

1993-04-08Labeling · Supplement 31AP
1992-11-16Labeling · Supplement 30AP
1991-10-28Labeling · Supplement 29AP
1991-03-05Labeling · Supplement 28AP
1990-08-06Labeling · Supplement 25AP
1990-03-28Manufacturing (CMC) · Supplement 19AP
1990-03-01Labeling · Supplement 24AP
1990-01-22Manufacturing (CMC) · Supplement 18AP
1990-01-22Manufacturing (CMC) · Supplement 22AP
1989-11-21Labeling · Supplement 23AP
1989-03-02Labeling · Supplement 21AP
1989-02-07Labeling · Supplement 20AP
1988-04-21Labeling · Supplement 16AP
1987-09-15Manufacturing (CMC) · Supplement 15AP
1987-09-08Manufacturing (CMC) · Supplement 12AP
1986-01-30Manufacturing (CMC) · Supplement 9AP
1985-12-03Manufacturing (CMC) · Supplement 7AP
1984-06-14Manufacturing (CMC) · Supplement 2AP
1984-06-14Manufacturing (CMC) · Supplement 3AP
1982-12-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →